Another study noted that sacubitril/valsartan in patients with CHF and atrial fibrillation leads to a significant decrease in the level of brain natriuretic peptide and showed a clear trend towards reversing myocardial remodeling (21). The gene discussed is NPPB; the disease is atrial fibrillation.